| scholarly article | Q13442814 |
| P50 | author | Benjamin Frey | Q38326649 |
| Alan G. Pockley | Q42945889 | ||
| P2093 | author name string | R Fietkau | |
| R Wunderlich | |||
| U S Gaipl | |||
| E-M Weiss | |||
| Y Rubner | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 1751-1764 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Current Medicinal Chemistry | Q3007710 |
| P1476 | title | Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies | |
| P478 | volume | 19 |
| Q38667899 | Abscopal Effects and Yttrium-90 Radioembolization. |
| Q92478240 | Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition |
| Q42222358 | Abscopal Effects: Case Report and Emerging Opportunities |
| Q51108391 | Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapy. |
| Q48238878 | Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model. |
| Q47899811 | Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences. |
| Q38139854 | Antitumor immune responses induced by ionizing irradiation and further immune stimulation |
| Q51551651 | Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity. |
| Q37525422 | Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells |
| Q60922811 | Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle |
| Q64248558 | Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System |
| Q26991721 | Combining radiation and immunotherapy: a new systemic therapy for solid tumors? |
| Q93060450 | Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases |
| Q37603804 | Current concepts in clinical radiation oncology |
| Q64374693 | Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models |
| Q61893824 | Die Rolle der Strahlentherapie bei der Induktion von Antitumor-Immunantworten |
| Q38788456 | Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients. |
| Q38525545 | Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer |
| Q28543176 | Enhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in mice |
| Q38868168 | Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines |
| Q38030920 | How does ionizing irradiation contribute to the induction of anti-tumor immunity? |
| Q37685388 | Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors. |
| Q33650058 | Immune Checkpoint in Glioblastoma: Promising and Challenging |
| Q92741127 | Immune biological rationales for the design of combined radio- and immunotherapies |
| Q87944374 | Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies |
| Q38641806 | Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors |
| Q37379408 | Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. |
| Q48193685 | Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. |
| Q99589745 | Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer |
| Q64943265 | Key mechanisms involved in ionizing radiation-induced systemic effects. A current review. |
| Q38217593 | Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy |
| Q26822491 | Local tumour ablative therapies: opportunities for maximising immune engagement and activation |
| Q36946100 | Locally advanced lung cancer: an optimal setting for vaccines and other immunotherapies. |
| Q36820444 | Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes |
| Q47718948 | Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study. |
| Q26744490 | Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation |
| Q38374300 | Modulations in the Peripheral Immune System of Glioblastoma Patient Is Connected to Therapy and Tumor Progression-A Case Report from the IMMO-GLIO-01 Trial |
| Q38018117 | Old and new facts about hyperthermia-induced modulations of the immune system |
| Q90031488 | Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases |
| Q61805065 | Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment |
| Q60959934 | Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect? |
| Q52145169 | Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin. |
| Q28081371 | Prospects of immune checkpoint modulators in the treatment of glioblastoma |
| Q55491553 | Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination. |
| Q36469945 | Radiation-induced effects and the immune system in cancer. |
| Q92063506 | Radiation-induced small extracellular vesicles as "carriages" promote tumor antigen release and trigger antitumor immunity |
| Q26779221 | Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications |
| Q39017268 | Radiotherapy and immunotherapy: a beneficial liaison? |
| Q90376845 | Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math |
| Q37376168 | Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers |
| Q98189272 | Resolution of a High Grade and Metastatic BK Polyomavirus-Associated Urothelial Cell Carcinoma Following Radical Allograft Nephroureterectomy and Immune Checkpoint Treatment: A Case Report |
| Q40179018 | SBRT for lung oligometastases: Who is the perfect candidate? |
| Q42448191 | Selected anti-tumor vaccines merit a place in multimodal tumor therapies |
| Q48310789 | Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer. |
| Q47558991 | TARGETED AND OFF-TARGET (BYSTANDER AND ABSCOPAL) EFFECTS OF RADIATION THERAPY: REDOX MECHANISMS AND RISK-BENEFIT ANALYSIS. |
| Q35828606 | Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model |
| Q90447436 | The Reduced Oligomerization of MAVS Mediated by ROS Enhances the Cellular Radioresistance |
| Q52666760 | The combination of ionizing radiation and proteasomal inhibition by bortezomib enhances the expression of NKG2D ligands in multiple myeloma cells. |
| Q42427640 | The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermia |
| Q64972619 | The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial. |
| Q42847992 | Trial Watch: Anticancer radioimmunotherapy |
| Q37666685 | Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C. |
Search more.